Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas

Gong J, Yan J, Forscher C, Hendifar A

Drug Design, Development and Therapy 2018, 12:777-786

Published Date: 6 April 2018